To reach more patients across Europe, we're now a part of

Discover more
 emovis-1795_1260px_version_2.jpg

Recruiting Numbers

emovis is not only known for its high recruiting numbers. It is also recognized for maintaining and/or exceeding the forecasted study participants recruiting prospects. The reason: emovis demonstrates high-level expertise and is open to innovation when recruiting patients and the Executive Management typically estimates the number of recruits in a conservative manner. A rule of fairness at emovis: Up to now, numerous sponsors were surprised and quite happy.

Search our past trials and recruitment numbers

Start Indication Sponsor Time period Recruited Trial Identifier
2006 Restless Legs Syndrome Boehringer Ingelheim Pharma GmbH & Co. KG 7 months 21 EudraCT-2005-006128-13
2009 Contraception Bayer Health Care AG 9 months 153 EudraCT-2009-010599-45
2009 Depression Steigerwald Arzneimittelwerk GmbH 8 months 95 EudraCT-2008-001417-26
2006 Irritable Bowel Syndrome GlaxoSmithKline PLC 3 months 28 n.d.
2006 Depression AstraZeneca PLC 4 months 13 EudraCT-2005-003745-14
2006 Generalized Anxiety Disorder AstraZeneca PLC 9 months 7 EudraCT-2005-005055-18
2006 Restless Legs Syndrome Axxonis Pharma AG 10 months 26 EudraCT-2004-001589-42
2012 Depression Institut de Recherches Internationales Servier n.d. 24 EudraCT-2010-024191-25
2006 Insomnia SANOFI-SYNTHELABO RECHERCHE 18 months 31 EudraCT-2005-003082-16
2006 Restless Legs Syndrome UCB (Schwarz Pharma) 6 months 21 EudraCT-2005-000428-18
2006 Restless Legs Syndrome UCB (Schwarz Pharma) 2 months 11 EudraCT-2005-0022611-25
2006 Depression Sanofi-Aventis Recherche & Développement 4 months 42 EudraCT-2004-002327-41
2004 Alzheimer's disease Sanofi n.d. 4 GDCT0030961
2006 Depression Institut de Recherches Internationales Servier 3 months 46 EudraCT-2004-004009-10
2004 Restless Legs Syndrome UCB (Schwarz Pharma), Imerem GmbH 6 months 20 n.d.
2006 Depression GlaxoSmithKline PLC 3 months 21 EudraCT-2006-001877-13
2004 Diabetic Neuropathy UCB (Schwarz Pharma) n.d. 13 n.d.
2005 Panic Disorder Elbion AG 1 month 12 EudraCT-2005-005708-17
2003 Depression Dr. Willmar Schwabe GmbH & Co. KG n.d. 4 n.d.
2005 Bronchitis Bionorica SE 2 weeks 3 EudraCT-2005-003249-15
2005 Premenstrual Syndrome Pfizer Inc. 8 months 3 EudraCT-2004-005173-27
2019 Vaccine Influenza Sanofi Pasteur SA 1 month 99 EudraCT-2019-000655-14
2005 Depression Eli Lilly and Company, Boehringer Ingelheim Pharma GmbH & Co. KG 7 months 9 EudraCT-2004-000167-95
2005 Generalized Anxiety Disorder Eli Lilly and Company, Boehringer Ingelheim Pharma GmbH & Co. KG 8 months 17 EudraCT-2004-002626-22
2021 Diabetic Neuropathy Bayer AG 4 months 8 EudraCT-2020-002066-14
2005 Irritable Bowel Syndrome Astellas Pharma Inc., Yamanouchi Europe B.V. 2 months 12 EudraCT-2004-003880-61
2019 Clostridium difficile Pfizer Inc. 18 months 20 EudraCT-2016-003866-14
2005 Depression GlaxoSmithKline PLC 2 months 1 EudraCT-2004-003803-19
2016 Vaccine Herpes Zoster GlaxoSmithKline PLC 4 months 11 EudraCT-2015-001778-17
2004 Generalized Anxiety Disorder Eli Lilly and Company, Boehringer Ingelheim Pharma GmbH & Co. KG 10 months 14 n.d.
2004 Social Phobia GlaxoSmithKline PLC 5 months 35 EudraCT-2004-000848-24
2021 COVID-19 Heidelberg ImmunoTherapeutics GmbH active 35 n.d.
2004 Irritable Bowel Syndrome GlaxoSmithKline PLC 5 months 49 EudraCT-2004-000848-24
2021 Endometriosis Bayer AG 5 months 4 EudraCT-2020-003131-16
2017 Alzheimer's disease Biogen Idec Research Limited 18 months 55 EudraCT-2015-000967-15
2004 Depression GlaxoSmithKline PLC 8 months 31 GDCT0259903
2021 Vaccine Influenza Seqirus UK Limited 3 weeks 61 EudraCT-2021-001721-40
2016 Irritable Bowel Syndrome Laves-Arzneimittel GmbH 4 months 11 EudraCT-2011-001743-78
2004 Depression Pfizer Inc. 3 months 27 EudraCT-2004-000562-13
2016 Irritable Bowel Syndrome SymbioPharm GmbH 5 months 33 EudraCT-2012-002741-38
2004 Alzheimer's disease GlaxoSmithKline PLC 8 months 2 EudraCT-2004-000985-12
2016 COPD AstraZeneca PLC 3 months 31 EudraCT-2015-005444-33
2016 Contraception Daiichi Sankyo Deutschland GmbH, Estetra SPRL 5 months 21 EudraCT-2013-005164-26
2004 Restless Legs Syndrome Boehringer Ingelheim Pharma GmbH & Co. KG 3 months 49 GDCT0062955
2016 Alzheimer's disease Boehringer Ingelheim Pharma GmbH & Co. KG 6 months 16 EudraCT-2013-005031-24
2016 Alzheimer's disease Boehringer Ingelheim Pharma GmbH & Co. KG 6 months 1 EudraCT-2013-005040-28
2010 Migraine Merck Sharp & Dohme LLC 3 months 27 EudraCT-2010-019288-13
2016 Pain ESPERION Therapeutics Inc., Boehringer Ingelheim Pharma GmbH & Co. KG 7 months 80 EUdraCT-2015-000404-25
2003 Depression Dr. Willmar Schwabe GmbH & Co. KG 14 months 58 n.d.
2015 Diabetes Mellitus Type II AstraZeneca PLC 4 months 9 EudraCT-2015-002376-24
2003 Alzheimer's disease Sanofi-Synthelabo 34 months 15 n.d.
2016 Hyperlipidemia ESPERION Therapeutics Inc. 6 months 12 EudraCT-2015-004136-36
2003 Depression H. Lundbeck A/S 7 months 21 n.d.
2021 Low Back Pain Vertanical GmbH active 31 EudraCT-2020-000107-36
2016 Gastrointestinal Reflux Disease (GERD) Reckitt Benckiser Healthcare (UK) Limited 5 months 47 EudraCT-2014-005261-69
2003 Restless Legs Syndrome UCB (Schwarz Pharma) 6 weeks 32 GDCT0063543
2021 Healthy Subjects Roche Diagnostics 4 weeks 175 n.d.
2016 Asthma AstraZeneca PLC 1 month 10 EudraCT- 2004-004042-41
2022 Allergy (Cat Hair) Regeneron Pharmaceuticals Inc. active 5 EudraCT-2021-002089-42
2016 Osteoarthritis PBB Entrepreneur Ltd. 4 months 56 GDCT0269718
2004 Alzheimer's disease Johnson & Johnson, Janssen-Cilag 4 months 5 n.d.
2021 Vaccine RSV Janssen Vaccines & Prevention B.V. 2,5 months 3 EudraCT-2021-001909-77
2016 Allergy (Grass pollen) ALLERGOPHARMA GmbH & Co. KG, Merck KGaA 2 months 33 EudraCT- 2015-002409-13
2003 Addiction (Nicotine) GlaxoSmithKline PLC 4 days 101 n.d.
2016 Depression Janssen Research & Development, LLC 10 months 3 EudraCT-2014-004587-38
2020 Alzheimer's disease Biogen GmbH 9 days 2 EudraCT-2019-004368-22
2016 Acute Infection Vertex Inc. 3 months 1 EudraCT-2014-004068-39
2021 Vaccine COVID-19 Bavarian Nordic A/S 5 months 163 EudraCT-2021-001393-31
2015 COPD Pearl Therapeutics Ltd. 4 months 29 EudraCT-2014-004712-10
2002 Migraine GlaxoSmithKline PLC 4 months 55 n.d.
2015 Fibromyalgia Daiichi Sankyo Development Ltd 4 months 5 EudraCT-2013-005164-26
2002 Restless Legs Syndrome Boehringer Ingelheim Pharma GmbH & Co. KG 3 months 35 GDCT0062484
2015 Addiction (Nicotine) Philip Morris Products S.A. 1 month 13 n.d.
2002 Restless Legs Syndrome GlaxoSmithKline PLC 3 months 16 GDCT50002921
2021 COVID-19 AiCuris Anti-Infective Cures GmbH 6 months 14 EudraCT-2021-000167-69
2015 COPD AstraZeneca PLC 4 months 31 EudraCT-2014-004715-37
2002 Restless Legs Syndrome GlaxoSmithKline PLC 2 weeks 9 GDCT0309879
2022 Menopausal Symptoms Bayer Consumer Care AG 9 months 21 EudraCT-2020-004855-34
2015 Depression Alkermes PLC 6 months 60 EudraCT-2014-000379-14
2002 Schizophrenia Janssen Research & Development, LLC, Johnson & Johnson 6 months 7 n.d.
2021 Healthy Subjects Heidelberg ImmunoTherapeutics GmbH 5 months 35 n.d.
2014 COPD GlaxoSmithKline PLC 2 months 15 EudraCT-2014-000611-14
2002 Depression Dr. Willmar Schwabe GmbH & Co. KG 10 months 13 n.d.
2020 Herpes Labialis Heidelberg ImmunoTherapeutics GmbH 22 months 259 EudraCT-2020-000926-24
2014 COPD GlaxoSmithKline PLC 6 weeks 12 EudraCT-2011-005914-12
2002 Generalized Anxiety Disorder Orion Pharma GmbH 5 months 35 n.d.
2020 Ulcerative Colitis Novartis Pharma AG active 4 EudraCT-2019-003113-34
2014 COPD Novartis Pharma GmbH 2 months 21 EudraCT-2013-001477-25
2002 Social Phobia GlaxoSmithKline PLC 3 months 25 n.d.
2020 Menopausal Symptoms Sojournix, Inc 3 months 24 EudraCT-2019-002281-12
2014 Vaccine Clostridium difficile Sanofi Pasteur SA 11 months 6 EudraCT-2013-000775-32
2001 Depression Servier Laboratories UK Ltd 3 months 9 n.d.
2018 Depression Janssen Research & Development, LLC 12 months 40 EudraCT-2015-005282-22
2014 Binge Eating Disorder Shire Development LLC 1 month 1 EudraCT-2012-004457-88
2001 Panic Disorder Pfizer Inc. 12 months 49 n.d.
2019 Common Cold Enzymatika AB, analyze & realize GmbH 4 months 90 n.d.
2016 Vaccine Influenza Janssen Research & Development, LLC 3 months 1 EudraCT-2014-004068-39
2013 COPD AstraZeneca PLC 3 months 20 EudraCT-2013-000116-14
2002 Restless Legs Syndrome GlaxoSmithKline PLC n.d. 8 GDCT0310475
2013 Vaccine Herpes Zoster GlaxoSmithKline PLC 1 month 16 EudraCT-2015-000965-30
2000 Depression Boehringer Ingelheim Pharma GmbH & Co. KG 12 months 60 n.d.
2013 Obstipation Ferring B.V. 6 months 24 EudraCT-2012-005588-28
2017 Migraine CoLucid Pharmaceuticals, Inc. 2 months 17 EudraCT-2015-005689-40
2006 Diabetic Neuropathy UCB (Schwarz Pharma) 4 months 19 EudraCT-2005-005788-27
2013 COPD GlaxoSmithKline PLC 1 week 2 EudraCT-2011-001644-29
2017 Insomnia Eisai Inc. 10 months 93 EudraCT-2015-004347-39
2009 Alzheimer's disease Eli Lilly and Company n.d. 10 EudraCT-2008-002758-39
2013 Binge Eating Disorder Shire Pharmaceuticals Group Plc 2 months 2 EudraCT-2012-003310-14
2017 Irritable Bowel Syndrome Dr. Willmar Schwabe GmbH & Co. KG 9 months 23 EudraCT-2014-004702-14
2012 Depression H. Lundbeck A/S, Otsuka Pharmaceutical 8 months 19 EudraCT-2012-001380-76
2017 Depression Janssen Research & Development, LLC 11 months 12 EudraCT-2016-001929-14
2012 Depression H. Lundbeck A/S n.d. 19 EudraCT-2011-001572-19
2012 Depression Merck Sharp & Dohme LLC 10 months 5 EudraCT-2011-005200-15
2017 Osteoarthritis Astellas Pharma Inc. 1 month 22 EudraCT-2014-004996-22
2012 Depression Shire Development LLC 12 months 44 EudraCT-2011-003018-17
2017 Prediabetes Glycemicon AG 15 months 62 n.d.
2004 Depression Pfizer Inc. n.d. 19 EudraCT-2004-000450-23
2012 Addiction (Nicotine) Pfizer, S.L.U. 2 years 371 EudraCT-2010-022914-15
2017 Vaccine Clostridium difficile Pfizer Inc. 17 months 30 EudraCT-2016-003866-14
2011 Alzheimer's disease Sanofi-Synthelabo n.d. 6 n.d.
2012 COPD AstraZeneca PLC 6 months 27 EudraCT-2011-001524-38
2016 Urinary Tract Infections Repha GmbH Biologische Arzneimittel 20 months 23 EudraCT-2013-004653-25
2012 Depression Shire Pharmaceutical Development Ltd n.d. 41 EudraCT-2011-003006-25
2012 Irritable Bowel Syndrome Laves-Arzneimittel GmbH 2 years 72 2011-001743-78
2017 Allergic Rhinitis ALK-Abelló Arzneimittel GmbH 1 month 8 EudraCT-2017-000971-97
2008 Vaccine Influenza GlaxoSmithKline PLC 2 months 38 EudraCT-2008-000872-25
2011 Alzheimer's disease Avraham Pharmaceuticals Ltd. 17 months 32 EudraCT-2011-004187-30
2017 COPD AstraZeneca PLC, Pearl Therapeutics Ltd. 1 month 18 EudraCT-2016-000154-34
2017 COPD Verona Pharma PLC 4 months 17 EudraCT-2016-005205-40
2022 Borderline Personality Disorder Oryzon active 39 EudraCT-2020-003469-20
2011 Alzheimer's disease Genentech Inc. 4 months 6 EudraCT-2010-021926-37
2017 Acute Infection Medicago Inc. 2 months 92 EudraCT-2017-001239-38
2011 Restless Legs Syndrome UCB Biosciences GmbH 4 months 47 EudraCT-2011-000053-23
2018 Alzheimer's disease Eisai Co., Ltd. 10 months 17 EudraCT-2016-003928-23
2004 Depression Eli Lilly and Company 3 months 56 GDCT0060310
2011 Venous insufficiency OM PHARMA SA 4 months 9 EudraCT-2009-013391-44
2018 Insomnia Idorsia Pharmaceuticals Ltd. 13 months 239 EudraCT-2017-004642-20
2007 Diabetic Neuropathy Swedish Orphan Biovitrum AB 2 months 1 EudraCT-2006-005967-25
2011 Psychiatric diagnosis, others Weleda AG 9 months 201 EudraCT-2010-024189-23
2018 Acute Infection Medicago Inc. 12 months 61 EudraCT-2018-001894-26
2022 COPD AstraZeneca PLC active 17 EudraCT-2022-001476-33
2011 Diabetes Mellitus Type II MetaCure (USA), Inc. 10 months 3 EudraCT-2010-020945-28
2018 Osteoarthritis Regeneron Pharmaceuticals Inc. 9 months 35 EudraCT-2017-001702-15
2022 Lichen simplex chronicus Kamari Pharma active 12 n.d.
2011 Depression Takeda Pharmaceutical Company Ltd. 5 months 46 EudraCT-2011-005298-22
2018 Onychomycosis Moberg Pharma AB 9 months 71 EudraCT-2016-001204-39
2022 Addiction (Nicotine) Philip Morris Products S.A. active 18 n. d.
2011 COPD GlaxoSmithKline PLC 9 months 21 EudraCT-2010-021802-39
2018 Insomnia Janssen Research & Development, LLC 4 months 32 EudraCT-2017-000980-33
2022 Vaccine Influenza Moderna active 119 EudraCT-2022-001638-12
2011 Hypertension Institut de Recherches Internationales Servier 6 months 5 EudraCT-2010-020945-28
2018 Premenstrual Syndrome Asarina Pharma AB 17 months 91 EudraCT-2017-000822-37
2023 Hypertension Alnylam Pharmaceuticals active 9 EudraCT-2021-003776-13
2011 Attention Deficit Hyperactive Disorder (adults) Novartis Pharmaceuticals 4 months 70 EudraCT-2011-004668-31
2018 Uterine Fibroid Bayer AG 10 months 11 EudraCT-2016-002855-48
2011 Depression AstraZeneca PLC 5 months 18 EudraCT-2010-019925-33
2016 Onychomycosis Polichem S.A. 4 months 59 EudraCT-2015-000561-31
2011 Stress Disorder Dr. Willmar Schwabe GmbH & Co. KG 4 months 31 EudraCT-2010-022114-12
2011 Diabetes Mellitus Type II Boehringer Ingelheim Pharma GmbH & Co. KG, Eli Lilly and Company 15 months 18 EudraCT-2010-021375-92
2015 COPD Novartis Pharma Services AG 4 months 15 EudraCT-2013-003127-11
2014 Diabetes Mellitus Type II Hanmi Pharm.Co.,Ltd. 5 months 1 EudraCT-2013-004250-13
2010 Common Cold Enzymatika AB, analyze & realize GmbH, Leiber GmbH 1 month 60 n.d.
2013 Depression Forest Research Institute 12 months 25 EudraCT-2012-001950-25
2012 COPD Allergan PLC, Almirall, S.A., AstraZeneca PLC 6 months 27 EudraCT-2011-001524-38
2011 COPD GlaxoSmithKline PLC 6 months 20 EudraCT-2010-021802-39
2010 Vaccine Influenza Sanofi Pasteur SA, Merck Sharp & Dohme LLC 2 months 108 EudraCT-2010-021068-13
2008 Generalized Anxiety Disorder H. Lundbeck A/S, Takeda Global Research & Development Centre (Europe) Ltd. 3 months 10 EudraCT-2008-001766-90
2008 Depression Takeda Global Research & Development Centre (Europe) Ltd. 8 months 28 EudraCT-2008-001580-11
2008 Diabetes Mellitus Type II Eli Lilly and Company 4 months 4 EudraCT-2008-004207-63
2010 Obstipation Shire Pharmaceuticals Group Plc, Shire-Movetis NV 32 months 16 EudraCT-2009-015719-42
2006 Metrorrhagia Bayer Schering Pharma AG 6 months 11 EudraCT-2005-004340-32
2010 Depression Sanofi-Aventis Recherche & Développement 7 months 33 EudraCT-2009-010339-42
2006 Parkinson Disease Axxonis Pharma AG 2 months 1 EudraCT-2006-003732-30
2006 Restless Legs Syndrome Boehringer Ingelheim Pharma GmbH & Co. KG 3 months 4 EudraCT-2005-005225-54
2003 Diabetes Mellitus Type II GlaxoSmithKline PLC 8 months 5 n.d.
2010 Depression GlaxoSmithKline PLC 4 months 22 EudraCT-2009-010339-42
2017 Psoriasis Novartis Pharma Services AG 4 months 4 EudraCT-2015-005170-38
2009 Addiction (Alcohol) H. Lundbeck A/S 11 months 121 EudraCT-2007-002315-92
2017 Hyperlipidemia ESPERION Therapeutics Inc., AstraZeneca PLC 2 months 4 EudraCT-2016-004115-12
2015 Depression Alkermes PLC 5 months 14 EudraCT-2014-000380-41
2017 Depression Janssen Research & Development, LLC 3 months 29 EudraCT-2015-005282-22
2009 Depression H. Lundbeck A/S 2 months 6 EudraCT-2007-001871-13
2018 Insomnia Idorsia Pharmaceuticals Ltd. 13 months 16 EudraCT-2017-004644-38
2009 Alzheimer's disease Institut de Recherches Internationales Servier 7 months 7 n.d.
2018 Depression Janssen-Cilag GmbH 3 months 32 EudraCT- 2017-002633-28
2009 Diabetes Mellitus Type II Novartis Pharma Services AG 7 months 6 EudraCT-2008-002758-39
2019 Depression Janssen Research & Development, LLC 5 months 14 EudraCT-2015-005282-23
2009 Restless Legs Syndrome Pfizer Inc. 6 months 16 EudraCT-2008-005889-32
2019 Irritable Bowel Syndrome Cosmo Pharmaceuticals NV 13 months 62 EudraCT-2016-004977-42
2009 Diabetes Mellitus Type II Boehringer Ingelheim Pharma GmbH & Co. KG 8 months 2 EudraCT-2008-008296-33
2019 Cardiovascular Diesase Novartis Pharmaceuticals 8 months 35 EudraCT-2018-003786-34
2009 Osteoarthritis Eli Lilly and Company 4 months 12 EudraCT-2009-010008-27
2018 Diabetes Mellitus Type II Novo Nordisk A/S 4 months 4 EudraCT-2017-003219-20
2019 Statin Intolerance ESPERION Therapeutics Inc. 9 days 3 EudraCT-2016-003485-11
2019 Obesity Novo Nordisk A/S 21 months 34 Eudra CT-2017-003380-35
2009 Depression Takeda Global Research & Development Centre (Europe) Ltd. 1 month 49 EudraCT-2008-001581-91
2019 Insomnia Idorsia Pharmaceuticals Ltd. 4 months 7 EudraCT-2017-004644-38
2009 Insomnia GlaxoSmithKline PLC 2 months 29 EudraCT-2008-006345-72
2019 Acute Infection Sanofi Pasteur SA 6 weeks 99 EudraCT-2019-000655-14
2019 Alopecia Areata Pfizer Inc. 4 months 3 EudraCT-2018-001714-14
2008 Vaccine Herpes Zoster Merck Sharp & Dohme LLC 8 months 844 EudraCT-2007-004020-20
2019 Atopic Dermatitis Pfizer Inc. 3 months 3 EudraCT-2018-003050-24
2008 Hypertension Novartis Pharma Services AG 4 months 18 EudraCT-2006-006068-44
2019 Hyperhidrosis Dr. August Wolff GmbH & Co. KG Arzneimittel 5 months 108 EudraCT-2017-004534-29
2019 Herpes Genitalis Heidelberg ImmunoTherapeutics GmbH 11 months 108 EudraCT-2019-000880-26
2008 Alzheimer's disease Eli Lilly and Company 1 month 3 EudraCT-2008-002758-39
2019 Psoriasis Pfizer Inc. 4 weeks 4 EudraCT-2018-003051-38
2019 Irritable Bowel Syndrome Repha GmbH Biologische Arzneimittel 18 months 4 EudraCT-2019-000245-12
2019 Irritable Bowel Syndrome SymbioPharm GmbH 22 months 17 EudraCT-2018-004626-28
2008 Irritable Bowel Syndrome Menarini Group 3 months 24 EudraCT-2008-000214-71
2019 Depression Allergan Inc 8 months 8 EudraCT-2018-002782-19
2008 Overactive Bladder (OAB) Pfizer Inc. 4 months 18 EudraCT-2007-006451-39
2020 Vaccine Tetanus-Diphtheria-Pertussis Vakzine Projekt Management GmbH 8 weeks 506 EudraCT-2019-002706-46
2008 Migraine Merck Sharp & Dohme LLC 3 months 55 EudraCT-2007-002667-28
2008 Low Back Pain Eli Lilly and Company 6 months 12 EudraCT-2008-002248-40
2008 Depression Sanofi-Aventis Recherche & Développement 6 months 29 EudraCT-2007-003863-31
2008 Diabetes Mellitus Type II Merck Sharp & Dohme LLC 1 month 4 EudraCT-2007-000145-35
2020 Depression Janssen-Cilag International NV 4 Wochen 3 EudraCT-2019-002992-33
2010 Depression H. Lundbeck A/S, Takeda Global Research & Development Centre (Europe) Ltd. 9 months 43 EudraCT-2008-001580-11
2008 Female Sexual Dysfunction Bayer Schering Pharma AG 4 months 13 Eudract-2006-004397-27
2020 Vasomotor Symptoms Sojournix Inc. 3 months 24 EudraCT-2019-002281-12
2008 Hyperlipidemia Merck Sharp & Dohme LLC 2 months 33 EudraCT-2011-001007-12
2008 Hypertension Takeda Pharmaceutical Company Ltd. 2 months 10 EudraCT-2007-002583-10
2007 Female Sexual Dysfunction Boehringer Ingelheim Pharma GmbH & Co. KG 11 months 60 EudraCT-2007-000032-68
2020 Vaccine Tuberculosis Vakzine Projekt Management GmbH 6 months 195 EudraCT-2020-001675-33
2007 Depression GlaxoSmithKline PLC 10 months 36 EudraCT-2005-003400-11
2020 Alopecia Areata Pfizer Inc. 3 months 4 EudraCT-2019-001084-71
2007 Depression Sanofi-Aventis Recherche & Développement 10 months 36 EudraCT-2004-002328-16
2007 Depression Institut de Recherches Internationales Servier 10 months 16 EudraCT-2006-004716-48
2007 Insomnia Sanofi-Aventis Recherche & Développement 12 months 14 EudraCT-2006-004942-18
2018 Prediabetes Novo Nordisk A/S 7 months 4 EudraCT-2017-003219-20
2016 Fibromyalgia Daiichi Sankyo Development Ltd 6 months 28 EudraCT-2013-005161-40
2007 Polyneuropathy Grünenthal GmbH 4 months 8 EudraCT-2006-003132-29
2016 Contraception Mithra Pharmaceuticals, Estetra SPRL 4 months 21 EudraCT-2015-003150-40
2007 Polyneuropathy Grünenthal GmbH 4 months 8 EudraCT-2006-003132-29
2007 Hypertension Daiichi Sankyo Europe GmbH 19 months 19 EudraCT-2006-003877-28
2015 Osteoarthritis Pro Bono Bio International Trading Ltd. 4 months 56 GDCT0269718
2007 Restless Legs Syndrome Boehringer Ingelheim Pharma GmbH & Co. KG 4 months 34 EudraCT-2006-006431-42
2014 Obesity Hanmi Pharm.Co.,Ltd. n.d. 52 EudraCT-2013-004251-21
2007 Migraine Merck Sharp & Dohme GmbH 5 months 35 EudraCT-2006-006187-35
2014 Binge Eating Disorder Shire Development LLC 1 month 1 EudraCT-2012-003313-34
2007 Generalized Anxiety Disorder Sanofi-Aventis Recherche & Développement 6 months 16 EudraCT-2006-002253-71
2007 Depression Pierre Fabre Médicament 5 months 11 EudraCT-2006-002404-34
2013 Vaccine Herpes Zoster, Vaccine Influenza GlaxoSmithKline PLC n.d. 16 EudraCT-2013-000372-15
2006 Social Phobia GlaxoSmithKline PLC 5 months 16 EudraCT-2006-003597-10
2010 Diabetes Mellitus Type II Boehringer Ingelheim Pharma GmbH & Co. KG 6 months 10 EudraCT-2009-013157-15
2010 Restless Legs Syndrome Mundipharma GmbH n.d. 21 EudraCT-2009-011107-23